Home > Products > API > Irinotecan
Irinotecan
  • IrinotecanIrinotecan

Irinotecan

Product nomen: Irinotecan
Formulae hypotheticae: C33H38N4O6
M. Pondus; 586.68
CAS Subcriptio Number; 97682-44-5

Model:CAS NO:97682-44-5

Mitte Inquisitionem

depictio producti

Irinotecan

Product nomen:Irinotecan 97682-44-5
CAS No:97682-44-5
Specification: in domo

Nomen Irinotecan
Synonyma Irinotecan(freeBase); Irinotecan(TECANS); 1,4'-Bipiperidine-1'-carboxylicacid(S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo -1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin -9-ylester;DQ-2805;(4S)-4,11-diethyl-4-hydroxy-9-[[(4-piperidinopiperidino)carbonyl]oxy]-3,4,12,14-tetrahydro-1H-pyrano [3',4':6,7]indolizino[1,2-b]quinoline-3,14-dione;SN 38Chemic albook-11. }.0^{15,20}]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl4-(piperidin-1-y l)piperidine-1-carboxylata;[1,4'-Bipiperidine]-1'-carboxylicacid,4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H- pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-ylester,(S)-
copyRight
M CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C33H38N4O6
M. Pondus 586.68
CAS Subcriptio Number 97682-44-5


Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Irinotecan, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept